Clinical Trial Update: Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-acetylcysteine (NAC) for the treatment of the common cold with cough has completed, with results posted on 2016-07-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Novartis | Conditions: Common Cold Associated With Cough | Phase 2 | Status: COMPLETED | Results posted: 2016-07-11